Molecular Staging - Crunchbase Company Profile & Funding

Q: Who invested in Molecular Staging?

Molecular Staging has 6 investors including CHL Medical Partners And Domain Associates.

Q: When was the last funding round for Molecular Staging?

Molecular Staging closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Molecular Staging raised to date?

Molecular Staging has raised obfuscated.

Overview

Molecular Staging

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Molecular Staging

CB Rank

404973

Molecular Staging is a life sciences tool company, develops technologies for the detection and measurement of proteins and nucleic acids.

Acquired by

Qiagen

Founded

obfuscation

Private

Grant

New Haven, Connecticut, United States

101-250

www.molecularstaging.com/

Biotechnology

Pharmaceutical

Funding Rounds

Grant

OBF

obfuscation

Grant

OBF

obfuscation

Series D

OBF

obfuscation

Details

Sub-Organization of

Qiagen

Legal Name

Molecular Staging, Inc.

Operating Status

Active

Company Type

For Profit

About the Company

Molecular Staging, Inc., a life sciences tool company, develops technologies for the detection and measurement of proteins and nucleic acids. It provides technologies for proteomics, genomics, pharmacogenomics, and diagnostics applications. The company’s products and services include protein microarrays analogous to the DNA microarray, enabling

researchers to study multiple proteins; whole-genome amplification that allows DNA samples as resources, enabling researchers to return to them for new tests or confirmatory diagnoses; and multiplexed diagnostics that enable earlier detection of disease.

Phone Number

(203) 772-5000

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AccuBlue® Broad Range dsDNA Quantitation Assay with DNA Standards

An assay kit for quantifying double-stranded DNA across a broad concentration range using provided DNA standards.

AccuDiag Human T4 'Thyroxine' ELISA Assay

An ELISA assay kit for measuring human thyroxine (T4) levels in samples using antibody-coated microtiter wells.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Molecular Staging	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Molecular Staging	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Molecular Staging	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Molecular Staging	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Molecular Staging	—	obfuscated obfuscation	—	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Molecular Staging	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Molecular Staging	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Molecular Staging	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Molecular Staging	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Molecular Staging	—	obfuscated obfuscation	—	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
CHL Medical Partners	—	Series D - Molecular Staging	—
CHL Medical Partners	—	Series D - Molecular Staging	—
CHL Medical Partners	—	Series D - Molecular Staging	—
CHL Medical Partners	—	Series D - Molecular Staging	—
CHL Medical Partners	—	Series D - Molecular Staging	—